Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
4 clinical trials · Condition
◉ Watch Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
| Record | Firm | Date |
|---|---|---|
| CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study (NCT06073574) | Ionis Pharmaceuticals, Inc. | 2021-03-31 |
| CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) (NCT04136171) | Ionis Pharmaceuticals, Inc. | 2020-03-13 |
Track Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) automatically
Every clearance here is in the API, with alerts when new ones post.